Document is current
Any future updates will be listed below
-
Authors
Panzavolta, Andrea https://orcid.org/0009-0004-9206-6206
Caffarra, Paolo
De Vita, Dalila
Dodich, Alessandra
Fonti, Cristina
L’Abbate, Federica
Lavorgna, Luigi
Laganà, Valentina
Marra, Camillo
Papagno, Costanza
Pellegrini, Francesca Ferrari
Stracciari, Andrea
Trojano, Luigi
Iaquinta, Tiziana
Pandolfi, Roberta
Calore, Monica
Sanzone, Sveva
Cappa, Stefano F.
Cerami, Chiara
-
Funding
Funding for this research was provided by:
Biogen (Biogen)
- License Information
-
More Information
Article History
Received: 4 July 2025
Accepted: 15 September 2025
First Online: 16 October 2025
Declarations
:
: The study protocol is approved by local Ethics Committee. Participants read and provided informed consent to the processing of data for research purposes.
: Monica Calore and Sveva Sanzone are employees of Biogen Italia and they may hold stock. Roberta Pandolfi is a former employee of Biogen and may hold stock. Tiziana Iaquinta is an employee of Xenia Reply. Stefano Cappa has received speaker honoraria from Biogen, Roche and Nutricia and has been member of the Scientific Advisory Board of Brain Control. Camillo Marra has been awarded grants as speaker and consultant by Biogen Eisai, Novo Nordisk, Angelini, PIAM, Eli Lilly. Andrea Panzavolta, Chiara Cerami, Paolo Caffarra, Dalila De Vita, Alessandra Dodich, Cristina Fonti, Federica L’Abbate, Valentina Laganà, Luigi Lavorgna, Costanza Papagno, Francesca Ferrari Pellegrini, Andrea Stracciari and Luigi Trojano have nothing to declare.
